--------------------------
OMB APPROVAL
-----------------------
OMB Number: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per response...14.90
--------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. _______________)*
Collaborative Clinical Research, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
194190 10 4
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 444903108 13G Page 2 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Oxford Bioscience Partners L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 3 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Oxford Bioscience Partners (Adjunct) L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 4 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
OBP Management L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 5 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Oxford Bioscience Partners (Bermuda) Limited Partnership
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda Limited Partnership
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 6 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
OBP Management (Bermuda) Limited Partnership
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda Limited Partnership
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 7 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
OBP Management (Bermuda) Ltd.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda Corporation
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 113,378 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
113,378 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
113,378 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.8%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 8 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Edmund M. Olivier
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 9 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Cornelius T. Ryan
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 444903108 13G Page 10 of 19 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Alan G. Walton
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 655,752 Shares
OWNED BY
EACH ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 0 Shares
WITH
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
655,752 Shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
655,752 Shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE>
NOTE: This Statement on Schedule 13G is being filed on behalf of (i) Oxford
Bioscience Partners L.P., a Delaware limited partnership; (ii) Oxford Bioscience
Partners (Adjunct) L.P., a Delaware limited partnership; (iii) OBP Management
L.P., a Delaware limited partnership; (iv) Oxford Bioscience Partners (Bermuda)
Limited Partnership, a Bermuda limited partnership; (v) OBP Management (Bermuda)
Limited Partnership, a Bermuda limited partnership; (vi) OBP Management
(Bermuda) Ltd., a Bermuda corporation; (vii) Edmund M. Olivier; (viii) Cornelius
T. Ryan; and (ix) Alan G. Walton.
Item 1(a). Name of Issuer: Collaborative Clinical Research, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
20600 Chagrin Blvd., Cleveland, Ohio 44122
Item 2(a) Item 2(b) Item 2(c)
--------- --------- ---------
Citizenship or Place
Name of Person Filing Address of Organization
--------------------- ------- ---------------
Oxford Bioscience Partners Oxford Bioscience Partners Delaware
L.P. ("OBP") 315 Post Road West
Westport, CT 06880
Oxford Bioscience Partners Oxford Bioscience Partners Delaware
(Adjunct) L.P. ("OBP 315 Post Road West
Adjunct") Westport, CT 06880
OBP Management L.P. ("OBP Oxford Bioscience Partners Delaware
Management"), the 315 Post Road West
general partner of OBP Westport, CT 06880
and OBP Adjunct
Oxford Bioscience Partners Richmond House Bermuda
(Bermuda) Limited Par-la-Ville Road
Partnership ("OBP Hamilton, Bermuda
Bermuda")
OBP Management (Bermuda) Richmond House Bermuda
L.P. ("OBP Management Par-la-Ville Road
Bermuda"), the general Hamilton, Bermuda
partner of OBP Bermuda
OBP Management Bermuda Ltd. Richmond House Bermuda
("Bermuda Corp.") a Par-la-Ville Road
general partner of OBP Hamilton, Bermuda
Management Bermuda
Edmund M. Olivier, a general Oxford Bioscience Partners United States
partner of OBP 650 Town Center Drive
Management and OBP Costa Mesa, California
Management Bermuda 92626
Cornelius T. Ryan, a general Oxford Bioscience Partners United States
partner of OBP 315 Post Road West
Management and OBP Westport, CT 06880
Management Bermuda
Alan G. Walton, a general Oxford Bioscience Partners United States
partner of OBP 315 Post Road West
Management and OBP Westport, CT 06880
Management Bermuda
Page 11 of Pages 19
<PAGE>
Item 2(d). Title of Class of Securities: Common Stock, $.01 par value.
Item 2(e). CUSIP Number: 194190 10 4
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) |_| Broker or Dealer registered under Section 15 of the
Securities Exchange Act of 1934 (the "Act").
(b) |_| Bank as defined in Section 3(a)(6) of the Act.
(c) |_| Insurance Company as defined in Section 3(a)(19) of the
Act.
(d) |_| Investment Company registered under Section 8 of the
Investment Company Act of 1940.
(e) |_| Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940.
(f) |_| Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income Security
Act of 1974 or Endowment Fund; see Rule
13d-1(b)(1)(ii)(F) of the Act.
(g) |_| Parent Holding Company, in accordance with Rule
13d-1(b)(ii)(G) of the Act.
(h) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(H) of the
Act.
None of the above.
Item 4. Ownership.
(a) Amount Beneficially Owned: As of December 31, 1996, each of
the following is the owner of record of the number of shares
of Common Stock set forth next to his, her or its name:
OBP: 408,690 Shares
OBP Adjunct: 130,517 Shares
OBP Management: 0 Shares
OBP Bermuda: 113,378 Shares
OBP Management Bermuda: 0 Shares
Bermuda Corp.: 0 Shares
Mr. Olivier: 0 Shares
Mr. Ryan: 0 Shares
Mr. Walton: 0 Shares
By virtue of their relationship as affiliated limited partnerships,
whose sole general partners share individual general partners, OBP,
OBP Adjunct and OBP Bermuda may be deemed to share voting power and
the power to direct the disposition of the shares of Common Stock
which each partnership owns of record. Additionally, OBP Management
owns presently exerciseable options to purchase an aggregate of
3,167 shares of Common Stock. Messrs. Ryan, Walton and Olivier are
general partners of both OBP Management, the general partner of OBP
and OBP Adjunct, and OBP Bermuda Management, the general
Page 12 of Pages 19
<PAGE>
partner OBP Bermuda. Therefore, each of Messrs. Ryan, Walton and
Olivier may be deemed to own beneficially the shares held by each
of OBP, OBP Adjunct and OBP Bermuda. Bermuda Corp. is deemed to
beneficially own the shares owned by OBP Bermuda, as it is solely a
general partner of OBP Bermuda Management, the general partner of
OBP Bermuda.
(b) Percent of Class:
OBP: 10.4%
OBP Adjunct: 10.4%
OBP Management: 10.4%
OBP Bermuda: 10.4%
OBP Management Bermuda: 10.4%
Bermuda Corp.: 1.8%
Mr. Olivier: 10.4%
Mr. Ryan: 10.4%
Mr. Walton: 10.4%
The foregoing percentages are calculated based on the 6,307,914
shares of Common Stock reported to be outstanding in the Quarterly
Report on Form 10-Q of Collaborative Clinical Research, Inc. for
the quarter ended September 30, 1996.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
OBP: 0 Shares
OBP Adjunct: 0 Shares
OBP Management: 0 Shares
OBP Bermuda: 0 Shares
OBP Management Bermuda: 0 Shares
Bermuda Corp.: 0 Shares
Mr. Olivier: 0 Shares
Mr. Ryan: 0 Shares
Mr. Walton: 0 Shares
(ii) shared power to vote or to direct the vote:
OBP: 655,752 Shares
OBP Adjunct: 655,752 Shares
OBP Management: 655,752 Shares
OBP Bermuda: 655,752 Shares
OBP Management Bermuda: 655,752 Shares
Bermuda Corp.: 113,378 Shares
Mr. Olivier: 655,752 Shares
Mr. Ryan: 655,752 Shares
Mr. Walton: 655,752 Shares
Page 13 of Pages 19
<PAGE>
(iii) sole power to dispose or to direct the disposition of:
OBP: 0 Shares
OBP Adjunct: 0 Shares
OBP Management: 0 Shares
OBP Bermuda: 0 Shares
OBP Management Bermuda: 0 Shares
Bermuda Corp.: 0 Shares
Mr. Olivier: 0 Shares
Mr. Ryan: 0 Shares
Mr. Walton: 0 Shares
(iv) shared power to dispose or to direct the disposition of:
OBP: 655,752 Shares
OBP Adjunct: 655,752 Shares
OBP Management: 655,752 Shares
OBP Bermuda: 655,752 Shares
OBP Management Bermuda: 655,752 Shares
Bermuda Corp.: 113,378 Shares
Mr. Olivier: 655,752 Shares
Mr. Ryan: 655,752 Shares
Mr. Walton: 655,752 Shares
Each of OBP, OBP Adjunct, OBP Management, OBP Bermuda, OBP
Management Bermuda, Bermuda Corp., Mr. Olivier, Mr. Ryan and Mr.
Walton expressly disclaims beneficial ownership of any shares of
Common Stock of Collaborative Clinical Research, Inc., except any
shares held directly of record.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following: |_|
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable. OBP, OBP Adjunct, OBP Management, OBP Bermuda, OBP
Management Bermuda, Bermuda Corp., Mr. Olivier, Mr. Ryan and Mr.
Walton expressly disclaim membership in a "group" as defined in
Rule 13d-1(b)(ii)(H).
Item 9. Notice of Dissolution of Group.
Not applicable.
Page 14 of Pages 19
<PAGE>
Item 10. Certification.
Not applicable. This statement on Schedule 13G is not filed
pursuant to Rule 13d-1(b).
Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each
of the filing persons pursuant to Rule 13d-1(f) under Section 13(d) of the Act.
Page 15 of Pages 19
<PAGE>
Signature
After reasonable inquiry and to the best of his, her or its knowledge and
belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct. We also hereby agree to file this
statement jointly pursuant to the agreement set forth as Exhibit 1 hereto.
Dated: February 12, 1997
OXFORD BIOSCIENCE PARTNERS L.P.
By: OBP Management L.P., its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OXFORD BIOSCIENCE PARTNERS (ADJUNCT) L.P.
By: OBP Management L.P., its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OXFORD BIOSCIENCE PARTNERS
(BERMUDA) LIMITED PARTNERSHIP
By: OBP Management (Bermuda) Limited
Partnership, its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OBP MANAGEMENT L.P.
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OBP MANAGEMENT (BERMUDA) LIMITED PARTNERSHIP
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
Page 16 of Pages 19
<PAGE>
OBP MANAGEMENT (BERMUDA) LTD.
By: /s/ Alan G. Walton
------------------------------------
Title: General Partner
/s/ Cornelius T. Ryan
------------------------------------
Cornelius T. Ryan
/s/ Alan G. Walton
------------------------------------
Alan G. Walton
/s/ Edmund M. Olivier
------------------------------------
Edmund M. Olivier
Page 17 of Pages 19
<PAGE>
Exhibit 1
AGREEMENT
Pursuant to Rule 13d-1(f) (1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13G need be filed with respect to the ownership by each of
the undersigned of shares of Common Stock of Collaborative Clinical Research,
Inc.
This Agreement may be executed in any number of counterparts, each of which
shall be deemed an original.
EXECUTED this 12th day of February, 1997.
OXFORD BIOSCIENCE PARTNERS L.P.
By: OBP Management L.P., its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OXFORD BIOSCIENCE PARTNERS (ADJUNCT) L.P.
By: OBP Management L.P., its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OXFORD BIOSCIENCE PARTNERS
(BERMUDA) LIMITED PARTNERSHIP
By: OBP Management (Bermuda) Limited
Partnership, its general partner
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OBP MANAGEMENT L.P.
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
Page 18 of Pages 19
<PAGE>
OBP MANAGEMENT (BERMUDA) LIMITED
PARTNERSHIP
By: /s/ Alan G. Walton
------------------------------------
Alan G. Walton
General Partner
OBP MANAGEMENT (BERMUDA) LTD.
By: /s/ Alan G. Walton
------------------------------------
Title: General Partner
/s/ Cornelius T. Ryan
------------------------------------
Cornelius T. Ryan
/s/ Alan G. Walton
------------------------------------
Alan G. Walton
/s/ Edmund M. Olivier
------------------------------------
Edmund M. Olivier
Page 19 of Pages 19
